Chonluten
Also known as: T-34, EDG peptide, Glu-Asp-Gly, Bronchogen
Chonluten is a synthetic tripeptide (Glu-Asp-Gly, EDG) short-peptide bioregulator developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It targets the bronchopulmonary system, where the Khavinson group reports it modulates gene expression in respiratory epithelium via direct peptide-DNA interaction in promoter regions. Evidence is limited to preclinical and small clinical studies from a single Russian research group; it is not FDA-approved and has no Western clinical validation.
Common research uses
Pricing for Chonluten
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
Average price
$2.69/mg
range $2.00–$3.50/mg
Sellers
4
from $39.99
45-day trend
-5.9%
vs 45-day avg $/mg
4 of 4 sellers have a current price
Top Merit pick
🇺🇸 BioLongevity Labs96via Disclosed Labs · just now
$3.50/mg +30.2% vs avg$69.97
20mg
99.3% purity 2 COAs- 🇺🇸 Peptide Plugs89
✓ verified at source · just now
$2.50/mg -7% vs avg$50.00
20mg
no purity - 🇺🇸 Verified Peptides86
via Disclosed Labs · just now
$2.75/mg +2.3% vs avg$55.00
20mg
no purity - peptidetech.isUnscored
via Disclosed Labs · just now
$2.00/mg -25.6% vs avg$39.99
20mg
no purity
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
COAs for Chonluten
3 third-party tests across 1 vendor. Each card links to the full report.
For
Chonluten
by Kimera Chems· batch KC-CLT-YET1
For
Chonluten
by BioLongevity Labs
Purity not on file
For
Chonluten
by BioLongevity Labs· batch 37-3-45777
3 citations indexed for Chonluten
Study · 2022
Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
This study evaluates the effects of five different peptides, the Epitalon ® tetrapeptide, the Vilon ® dipeptide, the Thymogen ® dipeptide, the Thymalin ® peptide complex, and the Chonluten ® tripeptide, as regulators of inflammatory and proliferative processes in the human monocytic THP-1, which is a human leukemia mon…
review · 2022
Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers
Ultrashort peptides (USPs), consisting of 2-7 amino-acid residues, are a group of signaling molecules that regulate gene expression and protein synthesis under normal conditions in various diseases and ageing. USPs serve as a basis for the development of drugs with a targeted mechanism of action.
review · 2020
Peptides: Prospects for Use in the Treatment of COVID-19
There is a vast practice of using antimalarial drugs, RAS inhibitors, serine protease inhibitors, inhibitors of the RNA-dependent RNA polymerase of the virus and immunosuppressants for the treatment of the severe form of COVID-19, which often occurs in patients with chronic diseases and older persons.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.